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Depletion of short-chain fatty acid (SCFA)-producing bacterial species in the gut 
microbiota is associated with poor health and higher disease prevalence in multiple 
non-communicable diseases, such as obesity, type 2 diabetes, and asthma. Butyrate 
is one of the major SCFAs in the human gut and has anti-tumoral and anti-
inflammatory effects, but little is known about the molecular mechanism governing 
the anti-inflammatory effects of butyrate on primary immune cells.  
Using human monocyte-derived dendritic cells (moDCs) activated with LPS and IFN-
γ (strong inducers of a type 1 immune response), we performed an investigation of 
butyrate's effects on 1) early intracellular signaling using global shotgun phospho-
proteomics, 2) transcriptional regulation using RNA-sequencing, and 3) production of 
cytokines, chemokines and co-stimulatory molecules by activated moDCs using flow 
cytometry and high-sensitivity immunoassays.  
In moDCs, butyrate redirected the development of a pro-inflammatory type 1 immune 
response in moDCs to a tissue-sustaining type 2-like phenotype. Integrative data 
analysis showed that butyrate had profound effects on the early transcriptional 
responses, which were in concordance with the phenotype that subsequently 
developed in butyrate-treated moDCs. These moDCs were characterized by IL-18 
production, inhibition of expression of pro-inflammatory cytokines such as IL-12p70 
and IL-23, and upregulation of expression of prostaglandin E2 synthase and 
efferocytotic genes, which together contribute to a tissue-sustaining and non-
inflammatory type 2-like phenotype. Together with data on butyrate-induced changes 
in genome-wide chromatin states, the proposed mechanism for butyrate's effective 
diversion of the LPS/IFN-γ-induced type 1 response in moDCs will be presented. In 
conclusion, the potent anti-inflammatory effects of butyrate to sustain tissue integrity 
in the gut may contribute to the association of butyrate with homeostatic gut 
conditions. 
